BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10809427)

  • 1. Direct effect of chronic cyclosporine treatment on collagen III mRNA expression and deposition in rat kidneys.
    Ceol M; Anglani F; Vianello D; Murer L; Del Prete D; Forino M; Favaro S; Gambaro G; D'Angelo A
    Clin Nephrol; 2000 Apr; 53(4):suppl 8-9. PubMed ID: 10809427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymerized type I collagen reduces chronic cyclosporine nephrotoxicity.
    Sánchez-Pozos K; Lee-Montiel F; Pérez-Villalva R; Uribe N; Gamba G; Bazan-Perkins B; Bobadilla NA
    Nephrol Dial Transplant; 2010 Jul; 25(7):2150-8. PubMed ID: 20139407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of transforming growth factor-beta-inducible gene-h3 in normal and cyclosporine-treated rat kidney.
    Sun BK; Li C; Lim SW; Jung JY; Lee SH; Kim IS; Kim YS; Kim J; Bang BK; Yang CW
    J Lab Clin Med; 2004 Mar; 143(3):175-83. PubMed ID: 15007308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of urokinase on renal interstitial inflammation in rats with chronic cyclosporine A nephropathy and its possible mechanism].
    Wang Y; Ma L; Tong JR; Luo ZM; He F
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):835-8. PubMed ID: 18504214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of tea polyphenols on transforming growth factor-beta1 expression in rat with cyclosporine A-induced chronic nephrotoxicity.
    Shi SH; Zheng SS; Jia CK; Zhu YF; Xie HY
    Acta Pharmacol Sin; 2004 Jan; 25(1):98-103. PubMed ID: 14704129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tranilast prevents the progression of chronic cyclosporine nephrotoxicity through regulation of transforming growth factor β/Smad pathways.
    Tao Y; Hu L; Li S; Liu Q; Wu X; Li D; Fu P; Wei D; Luo Z
    Transplant Proc; 2011 Jun; 43(5):1985-8. PubMed ID: 21693312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-transforming growth factor antibody at low but not high doses limits cyclosporine-mediated nephrotoxicity without altering rat cardiac allograft survival: potential of therapeutic applications.
    Khanna AK; Plummer MS; Hilton G; Pieper GM; Ledbetter S
    Circulation; 2004 Dec; 110(25):3822-9. PubMed ID: 15583082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of cyclosporin A combined with T4 on collagen IV production, coll alpha 1 (IV) mRNA and TGF beta 1 mRNA expression in cultured human mesangial cells].
    Su Y; Li X; Gao Y; Lin J; Li L
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Oct; 21(5):338-44. PubMed ID: 12567430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of anti-transforming growth factor-beta antibodies in cyclosporine-induced renal dysfunction.
    Islam M; Burke JF; McGowan TA; Zhu Y; Dunn SR; McCue P; Kanalas J; Sharma K
    Kidney Int; 2001 Feb; 59(2):498-506. PubMed ID: 11168932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of renal transforming growth factor-beta and its receptors in a rat model of chronic cyclosporine-induced nephropathy.
    Bing P; Maode L; Li F; Sheng H
    Transplant Proc; 2006 Sep; 38(7):2176-9. PubMed ID: 16980035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different renal toxicity profiles in the association of cyclosporine and tacrolimus with sirolimus in rats.
    Lloberas N; Torras J; Alperovich G; Cruzado JM; Giménez-Bonafé P; Herrero-Fresneda I; Franquesa Ml; Rama I; Grinyó JM
    Nephrol Dial Transplant; 2008 Oct; 23(10):3111-9. PubMed ID: 18469305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic cyclosporin A nephrotoxicity, P-glycoprotein overexpression, and relationships with intrarenal angiotensin II deposits.
    del Moral RG; Andujar M; Ramírez C; Gómez-Morales M; Masseroli M; Aguilar M; Olmo A; Arrebola F; Guillén M; García-Chicano MJ; Nogales FF; O'Valle F
    Am J Pathol; 1997 Dec; 151(6):1705-14. PubMed ID: 9403721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of spironolactone in an experimental model of chronic cyclosporine nephrotoxicity.
    Macunluoglu B; Arikan H; Atakan A; Tuglular S; Ulfer G; Cakalagaoglu F; Ozener C; Akoglu E
    Transplant Proc; 2008; 40(1):273-8. PubMed ID: 18261605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporin induces renal proto-oncogene RNA message and increased transforming growth factor-beta prior to renal fibrosis: Modification by calcium channel blockade in the salt replete rat.
    Saggi SJ; Andoh TF; Safirstein R; Bennett WM
    Nephrology (Carlton); 2004 Apr; 9(2):58-64. PubMed ID: 15056263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal protective effects of leukotriene receptor blockers in an experimental model of cyclosporine nephrotoxicity.
    Atakan A; Arikan H; Macunluoglu B; Tuglular S; Ulfer G; Cakalagaoglu F; Ozener C; Akoglu E
    Transplant Proc; 2008; 40(1):279-84. PubMed ID: 18261606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of leflunomide analogue FK778 on development of chronic rat renal allograft rejection and transforming growth factor-BETA expression.
    Rintala JM; Savikko J; Rintala SE; von Willebrand E
    Transplant Proc; 2006 Dec; 38(10):3239-40. PubMed ID: 17175234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Lotensin and Salviae on the changes of TGF-beta1 and its receptors in a rat model of chronic cyclosporine-induced nephropathy.
    Peng B; Li M; Niu T; He S
    Transplant Proc; 2006 Sep; 38(7):2183-6. PubMed ID: 16980037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renocortical mRNA expression of vasoactive factors during spironolactone protective effect in chronic cyclosporine nephrotoxicity.
    Pérez-Rojas JM; Derive S; Blanco JA; Cruz C; Martínez de la Maza L; Gamba G; Bobadilla NA
    Am J Physiol Renal Physiol; 2005 Nov; 289(5):F1020-30. PubMed ID: 15998842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of expression of TGF-beta1, its receptors TGFbeta1R-I and TGFbeta1R-II in rat kidneys during chronic nephropathy induced by cyclosporine and tacrolimus.
    Bing P; Maode L; Li F; Sheng H
    Transplant Proc; 2006 Sep; 38(7):2180-2. PubMed ID: 16980036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of transforming growth factor-beta and determination of apoptotic index in histopathological sections for assessment of the effects of Apigenin (4', 5', 7'- Trihydroxyflavone) on Cyclosporine A induced renal damage.
    Chong FW; Chakravarthi S; Nagaraja HS; Thanikachalam PM; Lee N
    Malays J Pathol; 2009 Jun; 31(1):35-43. PubMed ID: 19694312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.